Accessibility Menu
Solana logo

Solana(NASDAQ) HSDT

Current Price$1.64
Market Cap$95.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year-80%
1 Month+8%
Solana last closing stock price
MetricPriceDate
Last closeUSD 1.632026-07-24
Solana stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.26%USD 1.692026-07-17
1 month+7.95%USD 1.512026-06-24
3 month-24.54%USD 2.162026-04-24
Year to date-43.6%USD 2.892025-12-31
1 year-80.29%USD 8.272025-07-24
3 year-99.98%USD 7,346.252023-07-25
5 year-100%USD 590,625.002021-07-23
Since inception-100%USD 14,803,149.612014-07-03

Solana Financials at a Glance

Market Cap

$95.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$9.59M

Net Income (TTM)

-$136.85M

EPS (TTM)

-$109.67

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$1.64

Volume

6,715

Open

$1.69

Previous Close

$1.64

Daily Range

$1.63 - $1.69

52-Week Range

$1.19 - $25.50

Estimated Earnings Date

Aug 13, 2026

HSDT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Solana

Solana helps people manage digital assets and neurological health. Its main products include a device for brain-related therapy and a service for holding Solana tokens. These offerings support patients with neurological issues and investors seeking exposure to digital assets.

Products and Services

  • Digital Asset Treasury (90.9% of 2025 revenue): Manages and stakes Solana tokens (SOL) for yield, targeting investors seeking digital asset exposure.
  • PoNS Device (9.1% of 2025 revenue): Non-implantable device delivering mild electrical stimulation to the tongue, used for neurological disorders like multiple sclerosis and brain injury.
  • PoNS Therapy: Physical therapy program paired with the PoNS device, aimed at improving balance and gait in patients.
  • Direct-to-Patient Sales: Sells devices directly to patients and through clinics, mainly in the U.S. and Canada.
  • Staking and DeFi Services: Participates in decentralized finance protocols to generate yield from SOL holdings.

Growth and Expansion

  • Adopted digital asset treasury strategy focused on Solana tokens in September 2025.
  • Raised $508.8 million in PIPE offerings in September 2025, including $119 million in digital assets.
  • Formed partnerships with Pantera Capital and Summer Wisdom Holdings for advisory and trading management in 2025.
  • Signed a non-binding letter of intent with the Solana Foundation for collaboration in 2025.
  • Launched plans for an Asia-Pacific low-latency cluster to support staking and DeFi services in 2025.

What Makes Solana Stand Out

Solana combines digital asset management with medical device innovation, serving both investors and patients. Its focus on Solana token strategies and a unique neurostimulation device sets it apart. The company leverages partnerships and infrastructure to support both business lines.

Five Things You Need to Know

  • Revenue was $6.02 million in 2025, up 1057.7% from 2024.
  • Digital asset treasury made up 90.9% of 2025 revenue.
  • Gross profit was $5.52 million in 2025, reversing a loss in 2024.
  • Operating expenses rose to $249.36 million in 2025, up 1701% from 2024.
  • Net loss was $40.89 million in 2025, compared to $11.74 million in 2024.

Bottom Line

Solana has shifted from a medical device focus to digital asset management. Its dual business model reflects adaptability and a willingness to pursue new opportunities.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

21

CEO

Dane Carl Andreeff

Website

www.heliusmedical.com

Headquarters

Newtown, PA 18940, US

HSDT Financials

Key Financial Metrics (TTM)

Gross Margin

94.17%

Operating Margin

-196.64%

Net Income Margin

-1427.15%

Return on Equity

-155.31%

Return on Capital

-7.02%

Return on Assets

-68.18%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$95.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

58.39M

Volume

6.71K

Avg. Volume

299.13K

Financials (TTM)

Gross Profit

$9.03M

Operating Income

-$18.86M

EBITDA

-$135.55M

Operating Cash Flow

-$17.81M

Capital Expenditure

$0.00

Free Cash Flow

-$17.81M

Cash & ST Invst.

$4.40M

Total Debt

$0.00

Solana Performance Analysis

Solana annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 787,00050.8%
20232023-12-31USD 644,000-18.2%
20242024-12-31USD 520,000-19.3%
20252025-12-31USD 6,017,0001057.1%
Solana sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-12.2%
Q32025-09-301520.9%
Q42025-12-31650.1%
Q12026-03-31-30.7%
Solana annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -39,097.13-85.9%
20232023-12-31USD -10,918.92-72.1%
20242024-12-31USD -3,249.89-70.2%
20252025-12-31USD -1.85-99.9%
Solana sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-181.0%
Q32025-09-30-724.3%
Q42025-12-31112.9%
Q12026-03-31-130.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.62M

+7289.8%

Gross Profit

$3.44M

+4879.2%

Gross Margin

95.03%

N/A

Market Cap

$95.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.53M

N/A

Employees

21

N/A

Net Income

-$99.80M

-2500.3%

EBITDA

-$99.80M

-2505.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$4.40M

+296.3%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-68.18%

N/A

Return on Invested Capital

-9.53%

N/A

Free Cash Flow

-$4.83M

-36.6%

Operating Cash Flow

-$4.83M

-36.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OMOutset Medical, Inc.
$4.04-4.49%
NNOXNano-X Imaging Ltd.
$0.90-7.97%
SNWVSANUWAVE Health Inc.
$5.93+0.17%
TLSITriSalus Life Sciences, Inc.
$4.22-1.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About HSDT

What is the current price of Solana?

Solana is trading at $1.64 per share.

What is the 52-week range for Solana?

Over the past 52 weeks, Solana has traded between $1.19 and $25.50.

How much debt does Solana have?

As of the most recent reporting period, Solana reported total debt of $0.00.

How much cash does Solana have on hand?

Solana reported $4.40M in cash and cash equivalents in its most recent financial results.

What is Solana’s dividend yield?

Solana does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services